In rare cases mitomycin C (MMC) may induce cancer-associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
thrombocytopenia
mitomycin C
progressive renal failure
MMC
hemolytic anemia
mitomycin C
thrombocytopenia
MMC
hemolytic uremic syndrome
mitomycin C
hemolytic anemia
MMC
progressive renal failure
mitomycin C
hemolytic uremic syndrome
MMC